NVAX

Novavax, Inc.

$9.09
0.21 (2.36%) Today
Compare NVAX
Open
$8.92
Previous Close
$8.88
Day Range
$8.88 – $9.29
52-Week Range
$6.20 – $11.97
Volume
2.65M
Exchange
NasdaqGS

About NVAX

Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria.

Related